Compassionate Access to Medical Cannabis Act or Ryan’s Law
Cal. HSC § 1649.1
California Statutes
Unless the context requires otherwise, the following
definitions shall apply for purposes of this chapter: (a) “Compassionate Use Act of 1996” means the initiative measure enacted by the approval of Proposition at the November 5, 1996, statewide general election and found at
Section 11362.5, and any amendments to that act. (b)
(1) Except as provided in paragraph (2), “health care facility” means a health facility specified in subdivision (a), (c), (f), (i), or (
n) of
Section or a home health agency licensed pursuant to
Chapter 8 (commencing with
Section 1725) of Division 2.
(2) The meaning of “health care facility” shall not include any of the following: (
A) A chemical dependency recovery hospital. (
B) A state hospital. (
C) An emergency department of a health care facility, as specified in subdivision (
a) of
Section 1250, while the patient is receiving emergency services and care. (c) “Home health agency” means a private or public organization, including, but not limited to, any partnership, corporation, political subdivision of the state, or other government agency within the state, that provides, or arranges for the provision of, skilled nursing services, to persons in their temporary or permanent place of residence and is licensed pursuant to
Chapter 8 (commencing with
Section 1725) of Division 2. (d) “Medicinal cannabis” means cannabis or a cannabis product used in compliance with the Compassionate Use Act of and
Article 2.5 (commencing with
Section 11362.7) of
Chapter of Division 10. (e) “Patient” means an individual who meets one or both of the following criteria:
(1) Is terminally ill.
(2) Is over years of age with a chronic disease for which the patient has received a physician’s assessment declaring that the patient has a serious medical condition, as defined by subdivision (
h) of
Section 11362.7 and that the use of medicinal cannabis is appropriate. (f) “Terminally ill” means a medical condition resulting in a prognosis of life of one year or less, if the disease follows its natural course.